Photocure Advances FDA Reclassification of Blue Light Cystoscopy
Oslo, Norway, August 14, 2026 Photocure ASA has welcomed a new proposal from the U.S. Food and Drug Administration...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Oslo, Norway, August 14, 2026 Photocure ASA has welcomed a new proposal from the U.S. Food and Drug Administration...
New York, New York, August 13, 2026 Aidoc announced that its CAREâ„¢ Body CT Multi-Triage has received eligibility for...
NEW YORK, June 25, 2026 Aidoc announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
NEW YORK, April 29, 2026 Aidoc has announced the successful completion of a $150 million Series E funding round...
Boston, Massachusetts, January 21, 2026 — Aidoc, a global leader in clinical artificial intelligence, announced that the U.S. Food...
New York, NY — November 20, 2025 — Aidoc, a global leader in clinical artificial intelligence, announced a major...
